Literature DB >> 1312829

Expression and transforming activity of a variant of the heparin-binding fibroblast growth factor receptor (flg) gene resulting from splicing of the alpha exon at an alternate 3'-acceptor site.

G Yan1, F Wang, Y Fukabori, D Sussman, J Hou, W L McKeehan.   

Abstract

Splicing at an alternate 3'-acceptor site results in deletion of a CCCAG in the 5'-sequence of the exon coding for the NH2-terminal immunoglobulin-like disulfide loop of the heparin-binding fibroblast growth factor receptor (flg) alpha isoform. The result is an in-frame stop codon 138 base pairs after the first flg consensus translational initiation site. The next more favorable site predicts the same two loop intracellular receptor isoform, gamma, which was predicted from two different human cDNAs that arise by alternate use of two exons at the same site. Although expressed in normal tissue, the gamma mRNA is increased in rat prostate tumors and confers ability of anchorage-dependent cells expressing non-secreted heparin-binding fibroblast growth factors to grow in soft agar.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312829     DOI: 10.1016/0006-291x(92)90498-a

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Loss of heterozygosity and DNA methylation affect germline fibroblast growth factor receptor 4 polymorphism to direct allelic selection in breast cancer.

Authors:  Xuegong Zhu; Lei Zheng; Sylvia L Asa; Shereen Ezzat
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

2.  Genetic and epigenetic mechanisms down-regulate FGF receptor 2 to induce melanoma-associated antigen A in breast cancer.

Authors:  Xuegong Zhu; Sylvia L Asa; Shereen Ezzat
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

3.  Reconstitution of fibroblast growth factor receptor interactions in the yeast two hybrid system.

Authors:  R Aloni-Grinstein; A Seddon; A Yayon
Journal:  Mol Biotechnol       Date:  1999-06       Impact factor: 2.695

Review 4.  The molecular pathogenetic role of cell adhesion in endocrine neoplasia.

Authors:  S Ezzat; S L Asa
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

5.  Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis.

Authors:  Shereen Ezzat; Lei Zheng; Xian-Feng Zhu; Gillian E Wu; Sylvia L Asa
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

6.  Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy.

Authors:  G Yan; Y Fukabori; G McBride; S Nikolaropolous; W L McKeehan
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

7.  Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants.

Authors:  E Shi; M Kan; J Xu; F Wang; J Hou; W L McKeehan
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

8.  Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer.

Authors:  Xuegong Zhu; Sylvia L Asa; Shereen Ezzat
Journal:  Mol Endocrinol       Date:  2009-06-04

9.  Receptor phenotype underlies differential response of hepatocytes and nonparenchymal cells to heparin-binding fibroblast growth factor type 1 (aFGF) and type 2 (bFGF).

Authors:  M Kan; G C Yan; J Xu; M Nakahara; J Hou
Journal:  In Vitro Cell Dev Biol       Date:  1992 Jul-Aug

10.  The breast cancer susceptibility gene product fibroblast growth factor receptor 2 serves as a scaffold for regulation of NF-κB signaling.

Authors:  Wangzhi Wei; Wei Liu; Clarissa A Cassol; Weiyue Zheng; Sylvia L Asa; Shereen Ezzat
Journal:  Mol Cell Biol       Date:  2012-09-17       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.